This Article Full Text Full Text (PDF) Publisher's Note Erratum (v26,p1018) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Garcia, S. F. Articles by Weinfurt, K. Search for Related Content PubMed PubMed Citation Articles by Garcia, S. F. Articles by Weinfurt, K. Social Bookmarking                            What's this?

Standardizing Patient-Reported Outcomes Assessment in Cancer Clinical Trials: A Patient-Reported Outcomes Measurement Information System Initiative

Sofia F. Garcia, David Cella, Steven B. Clauser, Kathryn E. Flynn, Thomas Lad, Jin-Shei Lai, Bryce B. Reeve, Ashley Wilder Smith, Arthur A. Stone, Kevin Weinfurt

From the Center on Outcomes, Research and Education, Evanston Northwestern Healthcare, Evanston; Department of Psychiatry and Behavioral Sciences, Institute for Healthcare Studies, and Department of Pediatrics, Feinberg School of Medicine, Northwestern University; Hematology/Oncology Division, Stronger Hospital of Cook County, Chicago, IL; Outcomes Research Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD; Center for Clinical and Genetic Economics, Duke Clinical Research Institute; Departments of Psychiatry and Behavioral Sciences and Psychology and Neuroscience, Duke University, Durham, NC; and Department of Psychiatry and Behavioral Science, Stony Brook University, Stony Brook, NY

Address reprint requests to David Cella, PhD, Center on Outcomes, Research and Education (CORE), Evanston Northwestern Healthcare, 1001 University Pl, Suite 100, Evanston, Illinois 60201; e-mail: d-cella{at}northwestern.edu

Patient-reported outcomes (PROs), such as symptom scales or more broad-based health-related quality-of-life measures, play an important role in oncology clinical trials. They frequently are used to help evaluate cancer treatments, as well as for supportive and palliative oncology care. To be most beneficial, these PROs must be relevant to patients and clinicians, valid, and easily understood and interpreted. The Patient-Reported Outcomes Measurement Information System (PROMIS) Network, part of the National Institutes of Health Roadmap Initiative, aims to improve appreciably how PROs are selected and assessed in clinical research, including clinical trials. PROMIS is establishing a publicly available resource of standardized, accurate, and efficient PRO measures of major self-reported health domains (eg, pain, fatigue, emotional distress, physical function, social function) that are relevant across chronic illnesses including cancer. PROMIS is also developing measures of self-reported health domains specifically targeted to cancer, such as sleep/wake function, sexual function, cognitive function, and the psychosocial impacts of the illness experience (ie, stress response and coping; shifts in self-concept, social interactions, and spirituality). We outline the qualitative and quantitative methods by which PROMIS measures are being developed and adapted for use in clinical oncology research. At the core of this activity is the formation and application of item banks using item response theory modeling. We also present our work in the fatigue domain, including a short-form measure, as a sample of PROMIS methodology and work to date. Plans for future validation and application of PROMIS measures are discussed.

Supported by National Institutes of Health Grant No. U01AR052177 to the Center on Outcomes, Research and Education, Evanston Northwestern Healthcare, and Grant No. U01AR052186 to Duke University Medical Center. In addition to financial support, the sponsor reviewed and approved the study design and monitored its progress and results.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. Jhamb, C. Argyropoulos, J. L. Steel, L. Plantinga, A. W. Wu, N. E. Fink, N. R. Powe, K. B. Meyer, M. L. Unruh, and for the Choices for Healthy Outcomes in Caring for Correlates and Outcomes of Fatigue among Incident Dialysis Patients Clin. J. Am. Soc. Nephrol., November 1, 2009; 4(11): 1779 - 1786. [Abstract] [Full Text] [PDF]

				J. Pidala, C. Anasetti, and H. Jim Quality of life after allogeneic hematopoietic cell transplantation Blood, July 2, 2009; 114(1): 7 - 19. [Abstract] [Full Text] [PDF]

				D. Cella, B. B. Reeve, N. Rothrock, K. Webster, K. P. Weinfurt, and for the PROMIS Cooperative Group New Tools for Measuring Patient-reported Outcomes in Cancer Research: The Patient-reported Outcomes Measurement Information System (PROMIS) ASCO Educational Book, January 1, 2009; 2009(1): 533 - 539. [Abstract] [Full Text] [PDF]

				K. Kuroi, K. Shimozuma, Y. Ohashi, A. Takeuchi, T. Aranishi, S. Morita, S. Ohsumi, T. Watanabe, S. Bain, and F. H. Hausheer A Questionnaire Survey of Physicians' Perspectives Regarding the Assessment of Chemotherapy-induced Peripheral Neuropathy in Patients with Breast Cancer Jpn. J. Clin. Oncol., November 1, 2008; 38(11): 748 - 754. [Abstract] [Full Text] [PDF]

				S. B. Clauser, P. A. Ganz, J. Lipscomb, and B. B. Reeve Patient-Reported Outcomes Assessment in Cancer Trials: Evaluating and Enhancing the Payoff to Decision Making J. Clin. Oncol., November 10, 2007; 25(32): 5049 - 5050. [Full Text] [PDF]

				J. Lipscomb, B. B. Reeve, S. B. Clauser, J. S. Abrams, D. Watkins Bruner, L. B. Burke, A. M. Denicoff, P. A. Ganz, K. Gondek, L. M. Minasian, et al. Patient-Reported Outcomes Assessment in Cancer Trials: Taking Stock, Moving Forward J. Clin. Oncol., November 10, 2007; 25(32): 5133 - 5140. [Abstract] [Full Text] [PDF]